SutroVax Announces $85M Series C Finance led by TPG
FOSTER CITY, Calif., June 7, 2018 /PRNewswire/ — SutroVax, a biopharmaceutical company dedicated to the delivery of best-in-class conjugate vaccines and novel complex antigen-based vaccines to prevent serious infectious diseases,…